key: cord-0859408-o9blbmb0
authors: Han, Han; Wang, Chongwen; Yang, Xingsheng; Zheng, Shuai; Cheng, Xiaodan; Liu, Zhenzhen; Zhao, Baohua; Xiao, Rui
title: Rapid field determination of SARS-CoV-2 by a colorimetric and fluorescent dual-functional lateral flow immunoassay biosensor
date: 2021-10-09
journal: Sens Actuators B Chem
DOI: 10.1016/j.snb.2021.130897
sha: 47115538f27ecf50490c8f55b50b68fd51bdef12
doc_id: 859408
cord_uid: o9blbmb0

The rapid and accurate diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the early stage of virus infection can effectively prevent the spread of the virus and control the epidemic. Here, a colorimetric and fluorescent dual-functional lateral flow immunoassay (LFIA) biosensor was developed for the rapid and sensitive detection of spike 1 (S1) protein of SARS-CoV-2. A novel dual-functional immune label was fabricated by coating a single-layer shell formed by mixing 20 nm Au nanoparticles (Au NPs) and quantum dots (QDs) on SiO(2) core to produce strong colorimetric and fluorescence signals and ensure good monodispersity and high stability. The colorimetric signal was used for visual detection and rapid screening of suspected SARS-CoV-2 infection on sites. The fluorescence signal was utilized for sensitive and quantitative detection of virus infection at the early stage. The detection limits of detecting S1 protein via colorimetric and fluorescence functions of the biosensor were 1 and 0.033 ng/mL, respectively. Furthermore, we evaluated the performance of the biosensor for analyzing real samples. The novel biosensor developed herein had good repeatability, specificity and accuracy, which showed great potential as a tool for rapidly detecting SARS-CoV-2.

The 2019 coronavirus disease (COVID-19) is highly infectious, highly pathogenic, and has a high mortality rate that has caused a serious health problem worldwide. In the early stages of infection, patients often exhibit functional symptoms similar to those of ordinary flu, such as fever and dry cough. As viral infection progresses to the lower trachea and even to the lungs, the disease rapidly develops into a severe infection characterized by acute respiratory distress syndrome (ARDS), and the condition of patients with severe illness may deteriorate to organ dysfunction and even death [1] [2] [3] [4] . Globally, the World Health Organization (WHO) has reported over 150 million confirmed cases of COVID-19 as of May 11, 2021 , including about 3.2 million deaths [5] . Therefore, early diagnosis of SARS-CoV-2 and prompt isolation of patients are the keys to prevent the further spread and outbreak of the virus. A rapid and accurate method for diagnosing SARS-CoV-2 in the field is urgently warranted.

Two main diagnostic methods for COVID-19 are currently in use: nucleic acid test and serological test. Virus nucleic acid real time-PCR (RT-PCR) is the standard method for the clinical diagnosis of SARS-CoV-2 [6] [7] [8] . Although RT-PCR can achieve early and ultrasensitive detection, it requires professional technicians and expensive instruments; moreover, the testing time is long. These disadvantages impede the application of RT-PCR in point-of-care testing (POCT) in the field.

Detection of SARS-CoV-2 specific immunoglobulin (IgM and IgG) antibodies is a common POCT method for the diagnosis of COVID-19. However, studies have shown that specific IgM and IgG can only be detected at 2-3 weeks after J o u r n a l P r e -p r o o f SARS-CoV-2 infection [9] [10] [11] . Antibody detection is not suitable for the detection of asymptomatic patients and patients with early infection. Rapid antigen detection (RAD) is a type of POCT for specific antigens based on transverse flow assay (LFIA), which not only detects antigens in the early stages of infection, but also can be performed in a short period of time in the field [12, 13] . Notably, selection of appropriate antigens is the key to rapid antigen detection of SARS-CoV-2.

SARS-CoV-2 virus is a coronavirus with four major structural proteins: spikes, nucleocapsid proteins, membrane proteins, and envelope proteins. S protein is a very important surface protein of coronavirus, whose main function is to recognize host cell surface receptors and fuse with host cells and realize spread [1, 4] . Therefore, S protein is a potential target for clinical diagnosis. In this study, a rapid antigen detection based on LFIA targeting S protein was selected.

Signal probe is an important part of LFIA system, among which colloidal gold is the traditional signal label. Colloidal gold-based (Au-based) LFIA test can be accomplished without professional technicians, and the results can be read visually.

However, it has low sensitivity and poor quantitative ability [14, 15] . Various composite nanoparticles have been explored as signal markers to overcome the drawbacks of Au-based LFIA and improve detection performance. Such markers include fluorescent microspheres, carbon-based nanoparticles (NPs), surface-enhanced Raman scattering (SERS) nanomaterials, up-converting phosphors, and many others [15] [16] [17] [18] [19] . As a new type of fluorescent materials, quantum dots (QDs) have been applied to LFIA systems. QDs have the advantages of high photostability, J o u r n a l P r e -p r o o f narrow fluorescence emission spectra, and quantifiable fluorescence intensity [14, 17, 20] . Nonetheless, the clinical application of QD-based LFIA has limitations owing to the small particle size of QDs (5-20 nm) and their poor biocompatibility [17] . Thus, QDs are assembled on carrier materials (such as Fe 3 O 4 , polymer, SiO 2 , and latex) to prepare QD beads (QBs) [15, [18] [19] [20] [21] . Compared with QD-based LFIA, QB-based LFIA can produce a higher fluorescence signal and sensitivity [17, 22, 23] . What is noteworthy is that although QB-based LFIA has the capability of highly sensitive quantitative detection, the fluorescent material requires an additional excitation light source to observe the emitted light, which prevents POCT diagnosis from being applied in areas such as communities, schools, stations and other areas with poor medical resources.

In this study, we designed colorimetric fluorescent SiO 2 @Au/QD NPs with dual functionality as novel signal tags for rapid and sensitive detection of SARS-CoV-2 S1

by naked eye/fluorescence dual modes. SiO 2 @Au/QD is a typical core-shell structure material, which consists of mono-dispersed 200 nm SiO 2 as the core and a monolayer shell formed by mixing Au NPs and carboxyl QDs. For COVID-19 detection, our

proposed SiO 2 @Au/QD has three important advantages. Firstly, monodisperse SiO 2 cores ensure high stability of the material in complex solutions, thus allowing rapid detection of S-antigens in real biological samples without sample pretreatment.

Secondly, the 20 nm Au NPs on the surface of the SiO 2 core can generate a strong colorimetric signal, which benefits the rapid diagnosis of suspicious samples in resource-poor areas without complicated instruments. Thirdly, the dense distribution J o u r n a l P r e -p r o o f of QDs in the Au interstitial space provides a powerful fluorescence signal of LFIA strip for more sensitive and accurate quantification of viral S antigen, which offers a possible way to improve the detection rate of SARS-CoV-2 infection in the field. In addition, QDs also provide rich carboxyl sites that facilitate efficient coupling of anti-SARS-CoV-2 antibodies on the surface of signal tags. Under optimal conditions, the limits of detection (vLOD) for SARS-CoV-2 S1 protein by colorimetric function of the proposed biosensor reached 1 ng/mL. Moreover, the limit of detection (LOD)

for SARS-CoV-2 S1 using fluorescence function was 33 pg/mL. We also performed a scientifically exhaustive validation of the repeatability, specificity, and accuracy of the biosensor. It is worth noting that the biosensor based on SiO 2 @Au/QDs has the advantages of simple synthesis method, low cost and mass production, which can be effectively applied to poor areas lacking advanced detection personnel and equipment.

More importantly, the biosensor developed in this paper provides an effective method for rapid and accurate screening of SARS-CoV-2 infection and shows potential clinical applications. 

The amide group of the anti-S1 detection antibody was coupled to the carboxyl site of SiO 2 @Au/QDs by carbodiimide chemistry (Scheme 1b). The methods were as follows: 1 mL of SiO 2 @Au/QDs was centrifuged and resuspended in 1 mL of MES buffer (0.1 M, pH 6.0). Next, EDC (10 mM, 100 µL) and NHS (100 mM, 20 µL) were added to the mixture under sonication for 15 min to activate the carboxyl groups of SiO 2 @Au/QDs. The mixture was then purified by centrifugation and resuspended in 0.2 mL of 0.05% PBST solution (10 mM, pH 7.4), followed by incubation with 8 µg of anti S1 detection protein antibody for 2 hours. Then, 100 μL of 10% skim milk was added to seal the unreacted carboxyl groups of SiO 2 @Au/QD NPs. Finally, the immune-SiO 2 @Au/QDs were washed twice by centrifugation with 0.05% PBST buffer. The final product was resuspended in PBS (10 mM, pH 7.4) for later use.

The LFIA strip consists of three separate components, including the sample pad, the nitrocellulose membrane (NC membrane) and the absorbent pad (Scheme 1c). Two lines were sprayed on the NC membrane (CN140): the capture antibody (0.8 mg/mL) against SARS-CoV-2 S1 protein was sprayed onto the detection line (T line), and the goat anti-mouse IgG antibody (0.8 mg/mL) was coated onto the control line (C line),

The membrane was dried at 37°C for 2 hours. Subsequently, three components were assembled onto the PVC base plate. Two kinds of pads respectively overlap the NC membrane by 1.5 mm to ensure a smooth transfer of the sample solution. The J o u r n a l P r e -p r o o f integrated membranes were cut into individual 3 mm strips, which were stored in a desiccator at room temperature for use in the assay.

The colorimetric-fluorescence dual-functional SiO 2 @Au/QD NPs were synthesized by PEI-mediated LBL assembly strategy as illustrated in scheme 1 in three steps: (i) According to the UV-vis spectra (Fig. 1k) , the SiO 2 /Au curve had an obvious absorption peak at 527 nm, indicating that Au NPs had been successfully adsorbed on the surface of SiO 2 @PEI NPs. As can be seen from the SiO 2 @Au/QD curve, the peaks increased as the Au-to-QD concentration ratio increased (Fig. 2f) . The change in fluorescence intensity was opposite to that of UV absorption spectrum (Fig. 2g) .

The fluorescence intensity decreased as the Au-to-QD concentration ratios increased.

Therefore, we need to find the balance between colorimetric signal and fluorescence signal.

SiO 2 @Au/QDs with different Au-to-QD concentration ratios were made into an immune label to detect the SARS-CoV-2 S1 protein at a concentration of 1 ng/mL. As results were shown in the Fig. 2i , when the Au-to-QD concentration ratio was J o u r n a l P r e -p r o o f 12.5%-75%, the colorimetric signal of the LFIA band based on SiO 2 @Au/QDs was successively enhanced, while the fluorescence signal was weakened. As can be seen from the Fig. 2i(i) , the colorimetric signals of LFIA bands with ratios of 12.5% and 25%

were not obvious enough to be observed. Whereas, the colorimetric band was easily visible at the Au-to-QD concentration ratio of 50% and could be used for qualitative detection. Fluorescent signals of the strips were observed by a UV lamp in Fig. 2i(ii) and the fluorescent signals intensity on LFIA strips were measured (Fig. 2h) . The detection results of 50% Au-to-QD concentration ratio achieved the highest signal-to-noise ratio (SNR). Hence, SiO 2 @Au NPs with 50% Au-to-QD ratio was selected as the optimal material to achieve the best detection of colorimetric and fluorescent signals. 

SiO 2 @Au/QD Scheme 1. described the preparation and operating principle of the SiO 2 @Au/QDs-based LFIA biosensor for SARS-CoV-2 S1 protein detection. First, a capture antibody and a goat anti-mouse IgG antibody were sprayed on the detection line and the control line of LFIA, respectively. The S1 protein was then diluted to different concentrations with PBS, and the immune tag and the diluted proteins were added to the running buffer, where the S1 protein was immunologically bound to the detection antibody to form a SiO 2 @Au/QD-S1 protein immune complex. Finally, the mixture was loaded onto the sample pad of the LFIA strip and moved in the direction of the absorbent pad with capillary action. When the immune complex reached the position of the test line, the S1 protein reacted with the capturing antibody. The residual SiO 2 @Au/QD nanotags continued to migrate and were captured by the goat anti-mouse IgG fixed on the control line. Therefore, a bright colorimetric/fluorescence control line was observed, indicating that the LFIA strips were working properly. The test line showed colorimetric and fluorescent bands when the S1 protein was present J o u r n a l P r e -p r o o f in the sample, whereas no bands appeared on the test line in the absence of the S1 protein in the test sample.

Two aspects were optimized to achieve the best detection results: (i) optimization of the immune labels and (ii) optimization of the conditions of the LFIA system. First, immune tags were prepared by detection antibodies conjugated to carboxyl groups on the surface of SiO 2 @Au/QDs via carbodiimide chemistry. The optimal amount of antibody to use was determined by modifying different amounts of the anti-S1 protein antibodies on activated SiO 2 @Au/QDs and then measuring their zeta potential (Fig.   S4a ). The potential of immune SiO 2 @Au/QDs decreased as the amount of the antibody increased (5-10 μg/mL) and stabilized at -24 mV, indicating that the antibody on the surface of SiO 2 @Au/QDs had reached the saturation state. The maximum loading capacity of the antibodies on SiO 2 @Au/QDs was 8 μg/mL.

Next is the optimization of the conditions of the LFIA system. This assay was designed with the following key parameters as the starting points: type of NC membrane, reaction time, antibody concentration on the test line, composition of running buffer, and volume of immune label added. NC membranes with two pore sizes, namely, CN 95 (15 mm pore size) and CN 140 (8 mm pore size), were tested.

Results showed that SiO 2 @Au/QD NPs could be transported smoothly on both membranes. Given that CN140 had a smaller pore size than CN 95, the sample ran slower on the chromatographic strip, and its binding time with the detection line was longer. Thus, CN140 could produce a higher fluorescence detection signal than CN 95.

Hence, CN140 was chosen as the ideal NC membrane in this experiment (Fig. S4b) . It

is worth mentioning that the detection results could be observed in 10 min, and the SNR reached the highest at 30 min (Fig. S5) . Optimization of the other LFIA system conditions is described in Supporting Information (Figs. S6-S8 ). 

All optimized conditions were applied to detect SARS-CoV-2 S1 protein and evaluate the sensitivity of SiO 2 @Au/QDs-based LFIA biosensor. The SARS-CoV-2 S1 protein was serially diluted from 1000 ng/mL to 0.05 ng/mL for eight concentrations and then loaded onto the strip biosensor. The control lines of all LFIA strips showed purple and fluorescent bands (Fig. 3b) , indicating that the strip biosensor was working properly. The purple band was due to the local surface plasmon resonance effect of Au NPs, and the fluorescence band was revealed by the excitation of 356 nm UV light. No purple or fluorescent bands were detected on the test line (T line) of the blank, proving the reliability of the test results of the biosensor.

As can be seen from Fig. 3c(i) , the vLOD of S1 protein detected by SiO 2 @Au/QD-LFIA colorimetric function was 1 ng/mL. Moreover, the visual sensitivity of fluorescence detection for S1 protein was 0.1 ng/mL (Fig. 3c[ii] ).

Fluorescence intensity on the T line was then recorded using a portable fluorometer, and a fitted curve (Fig. 3e ) was plotted on the basis of the data obtained. The graph showed that fluorescence intensity was proportional to the concentrations of S1

proteins within the detection range of 0.05-1,000 ng/mL. Based on the calibration curves, the LOD of fluorescence detection for S1 protein calculated by IUPAC standard method was 33 pg/mL (LOD = y blank + 3 × SD blank , where y blank is the mean signal intensity of blank group, and SD blank is the standard deviation of the blank measurement). It has been reported that the average amount of S protein in saliva was estimated in the ρM range in most cases, and in severe cases in the nM range. [7, 25, 26] In this study, the vLOD of S protein detected by SiO 2 @Au/QDs-LFIA colorimetric function was 0.02 nM. Moreover, the LOD of fluorescence detection for S protein was 0.67 ρM. Therefore, our proposed biosensor can screen patients with different degrees of disease within a certain range.

In order to prove the superiority of our proposed method, we compared the detection performance of SiO 2 @Au/QD-LFIA with the commonly used Au NPs-LFIA in the market. Under the same optimization conditions as SiO 2 @Au/QD-LFIA, the J o u r n a l P r e -p r o o f vLOD of SiO 2 @Au/QD-LFIA colorimetric function for S1 protein detection was 10 times that of Au NPs-LFIA by comparing Fig. 3a and Fig. 3c . Based on the calculated results of IUPAC standard method and Fig. 3a , the LOD of S1 protein detected by fluorescence function of SiO 2 @Au/QD-LFIA was 300 times that of Au NPs-LFIA.

Those results proved the excellent colorimetric and fluorescence detection capability of the bifunctional biosensor. In addition, the results of this study were also compared with previously reported results from other LFIA tests for SARS-CoV-2 antigens, (Table 1) . Table S1 in the support information.

As shown in Fig. 4a , the repeatability of SiO 2 @Au/QD-LFIA was evaluated. The S1 protein was diluted into a high-dose group of 100 ng/mL and a medium-dose group of 1 ng/mL to perform five independent experiments. Purple and fluorescent bands were observed in both groups. Moreover, the relative standard deviation of fluorescence intensity was 6.89% and 7.16%, indicating that the prepared SiO 2 @Au/QD-based LFIA strips had high reliability and repeatability. Next is the evaluation of the specificity of the SiO 2 @Au/QD-based LFIA strips. Several respiratory viruses including SARS-CoV (100 ng/mL), MERS-CoV (100 ng/mL), H1N1 (5×10 6 copies/mL), Flu-B (5×10 4 copies/mL), RSV (5×10 5 pfu/mL) and ADV (5 μg/mL) were used as interferents to test the specificity of the biosensor (Fig. 4b) .

The color or signal of these six virus strains did not change, and only the J o u r n a l P r e -p r o o f SARS-CoV-2 group produced evident colorimetric and fluorescence signals, indicating that the LFIA band based on SiO 2 @Au/QDs had good specificity. Finally, the accuracy of the biosensor in practical applications was evaluated by spiking the S1 protein into sputum and Tween (1%, V/V) mixture to simulate the detection of actual sample (Fig. 4c) . The clinical samples were collected from the patient's throat and nose swab. The S1 protein was diluted into three concentrations of 100, 1, and 0.1 ng/mL, and the experiment was repeated three times. The recoveries corresponding to the three concentrations were 92.98%, 94.91%, and 99.26% (Table S1 ), respectively, indicating that the acceptable accuracy of novel biosensor for quantification of S1

proteins. Table S2 in the support information.

The continuously diluted from 1.41 × 10 7 copies/mL to 7.06 × 10 3 copies/mL in 8 concentrations, and then virus diluents were dropped on the sample pads. All the tomographic strips showed C lines (Fig.5a) , proving that biosensors were working normally. It could be observed with the naked eyes that the limit of the detection for virions by SiO 2 @Au/QD-LFIA colorimetric function was 7.06×10 5 copies/mL ( Fig.   5a [i]). Base on the result of quantification for S proteins by ELISA, the concentration of S protein on the virus at vLOD was calculated to be 2.55 ng/mL. These results indicated that SiO 2 @Au/QD-LFIA still had good performance in colorimetric detecting S proteins on real viruses. Notably, the visual sensitivity of fluorescence detection for S proteins on virions was 7.06×10 4 copies/mL (Fig. 5a[ii] ). According to the results of portable fluorometer measurement and the fitting curve (Fig. 3f) , the LOD of SiO 2 @Au/QD-LFIA fluorescence detection for virions was calculated to be 1.02×10 4 copies/mL. Based on the results of ELISA, we calculated the LOD of S proteins on the inactivated viruses was 37 pg/mL, which was consistent with the detection sensitivity of standard S1 proteins indicating that SiO 2 @Au/QD-LFIA had stable analytical ability in detecting real viruses.

Furthermore, the specificity and reliability of dual-function biosensor were evaluated by adding virions to saliva samples. We selected respiratory infectious viruses that cause symptoms similar to COVID-19 to verify the specificity of LFIA including H1N1 (5×10 6 copies/mL), Flu-B (5×10 4 copies/mL), ADV (5×10 5 pfu/mL) and RSV (5 μg/mL). As can be seen in Fig 4b, clear and bright bands appeared on the immunochromatographic strip only when SARS-CoV-2 virions were detected. While the false positives (non-specific binding) did not occur after the addition of high concentrations of interferers, which further proved the specificity of this detection method for COVID-19 detection. The accuracy of the biosensor in complex samples was also evaluated (Fig. 5d) . We measured the fluorescence signal of T line and calculated the recoveries of positive samples. The recoveries for the mixtures of virions and saliva ranged from 93.63% to 98.02%, with low coefficient of variation (CV) ranging from 3.92% to 5.19% (Table S2) . These results confirmed the novel biosensor has excellent accuracy and applicability for detection of SARS-CoV-2 in real samples. 

In this paper, the synthesis of a novel colorimetric and fluorescent bifunctional SiO 2 @Au/QDs was reported. This study was the first to introduce this new material into the LFIA system as a label for detecting the S1 protein of SARS-CoV-2.

SiO 2 @Au/QDs were prepared by coating a monolayer shell of Au and QDs onto a 200 nm SiO 2 core via PEI-mediated LBL assembly method. This kind of material displayed high dispersion and excellent stability with both colorimetric and fluorescence detection characteristics Under optimal conditions, the S1 protein of SARS-CoV-2 was detected by the SiO 2 @Au/QD-based LFIA biosensor within 30 min.

The detection limits of the detected S1 proteins using the colorimetric and fluorescence functions were 1 ng/mL and 33 pg/mL, respectively. In addition, the specificity, accuracy and real sample detection of the biosensor were fully validated.

Therefore, the biosensor developed herein has the potential for rapid and accurate detection of SARS-CoV-2. In practical application, the colorimetric function of the new biosensor can make an on-site diagnosis without instruments for critically ill patients. Fluorescence mode allows highly sensitive and quantitative detection to screen patients with common symptoms. Moreover, the proposed SiO 2 @Au/QDs-based LFIA system can be applied to rapid and sensitive diagnosis of other pathogens by using different specific antibodies and has a broad application prospect. 

SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract

Clinical Characteristics of Coronavirus Disease 2019 in China

Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection

World Health Organization, COVID-19 Weekly Epidemiological Update

A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)

Virological assessment of hospitalized patients with COVID-2019

Diagnostic methods and potential portable biosensors for coronavirus disease 2019

Antibody responses to SARS-CoV-2 in patients with COVID-19

Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China

Detection of IgM and IgG antibodies in patients with coronavirus disease

Challenges of SERS technology as a non-nucleic acid or -antigen detection method for SARS-CoV-2 virus and its variants

Ultrasensitive, and Quantitative Detection of SARS-CoV-2 Using Antisense Oligonucleotides Directed Electrochemical Biosensor Chip

Comparative study of colloidal gold and quantum dots as labels for multiplex screening tests for multi-mycotoxin detection

Magnetic Lateral Flow Immunoassays, Diagnostics (Basel)

Recent advances in nanoparticle-based lateral flow immunoassay as a point-of-care diagnostic tool for infectious agents and diseases

Quantitative and simultaneous detection of two inflammation biomarkers via a fluorescent lateral flow immunoassay using dual-color SiO2@QD nanotags

Rapid, Quantitative, High-Sensitive Detection of Escherichia coli O157:H7 by Gold-Shell Silica-Core Nanospheres-Based Surface-Enhanced Raman Scattering Lateral Flow Immunoassay

A rapid SERS method for label-free bacteria detection using polyethylenimine-modified Au-coated magnetic microspheres and Au@Ag nanoparticles

Layer-by-layer assembly of magnetic-core dual quantum dot-shell nanocomposites for fluorescence lateral flow detection of bacteria

Magnetic Quantum Dot Nanobead-Based Fluorescent Immunochromatographic Assay for the Highly

Quantum dot nanobead-based multiplexed immunochromatographic assay for simultaneous detection of aflatoxin B1 and zearalenone

Size-dependent Immunochromatographic Assay with Quantum Dot

A Thermostable mRNA Vaccine against COVID-19

A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2)

Nanozyme chemiluminescence paper test for rapid and sensitive detection of SARS-CoV-2 antigen

SARS-CoV-2 Coronavirus Nucleocapsid Antigen-Detecting Half-Strip Lateral Flow Assay Toward the Development of Point of Care Tests Using Commercially Available Reagents

Development of a SARS-CoV-2-specific biosensor for antigen detection using scFv-Fc fusion proteins

Development of an ultrasensitive fluorescent immunochromatographic assay based on multilayer quantum dot nanobead for simultaneous detection of SARS-CoV-2 antigen and influenza A virus

Spike Variants

5G-enabled ultra-sensitive fluorescence sensor for proactive prognosis of COVID-19

Methodology, Writing -original draft. Chongwen Wang: Conceptualization, Writing -review & editing. Xingsheng Yang: Methodology. Shuai Zheng: Methodology, Writing -original draft

Methodology, Data curation. Zhenzhen Liu: Methodology. Baohua Zhao: Writing -review & editing. Rui Xiao: Funding acquisition, Writing -review & editing

This study was supported by the Youth Development Program (Grant no.